The program is still filling in: some talks have no title yet and more speakers will be added. We’ll add new sessions, the organizations presenting them and stand numbers once the floor plan is published.

Universities and research institutes at Festival of Biologics USA 2027

Apr 13–14, 2027 Boston, MA ~2k attendees Website

25 universities and research institutes are at Festival of Biologics USA 2027 — 25 presentations on the program. Most represented: UC San Diego (2 on the program), University of Pennsylvania (2 on the program), Amsterdam UMC (1 on the program). 2 of them have their own page in this guide. As of Oct 15, 2026.

All 126 organizations at Festival of Biologics USA 2027 →

Showing 1–19 of 25 organizations

Organization	Festival of Biologics USA 2027 Attendance
UC San Diego San Diego, CA
	Talk Tue Apr 13 13:50 Bioprocessing to make biosimilars accessible Biosimilars Talk Tue Apr 13 16:40 Leveraging AI in Computational Medicine AI & Data
University of Pennsylvania Philadelphia, PA
	Talk Tue Apr 13 13:50 AI driven trial design and optimization AI & Data Talk Tue Apr 13 13:50 Engineering protein scaffolds for novel bispecific antibodies Protein Engineering
Amsterdam UMC Amsterdam, Netherlands
	Talk Tue Apr 13 12:00 Cancer immunotherapy using bispecific gamma delta T cell engagers Antibodies for Immunotherapy
Biodesign Institute, Arizona State University Tempe, AZ
	Talk Tue Apr 13 17:40 Enhanced Antibody Effector Function Through Glycoengineering mAbs
Boston College Chestnut Hill, MA
	Talk Wed Apr 14 14:20 Precision Bioconjugation to Build Next-Generation Biotherapeutics How building unnatural amino acids into proteins lets chemists attach molecules at chosen spots and numbers, fine-tuning how protein drugs behave.
Chapman University Orange, CA
	Talk Wed Apr 14 14:00 From Discovery to Market: U.S. Leadership in Gene Therapy Innovation Advanced Therapies
Complex Carbohydrate Research Center Athens, GA
	Talk Tue Apr 13 15:10 Analytical development and characterization of biosimilars Biosimilars
Dana-Farber Cancer Institute Boston, MA
	Talk Wed Apr 14 11:20 Advances in PD-1 Agonists Oncology
Fred Hutch Cancer Center Seattle, WA
	Talk Wed Apr 14 13:20 Next generation mAbs: new frontiers in cancer treatment Oncology
Johns Hopkins University Baltimore, MD
	Talk Tue Apr 13 16:40 Engineered cytokine/antibody fusion proteins as novel drugs for cancer immunotherapy Protein Engineering
Kennesaw State University Kennesaw, GA
	Talk Wed Apr 14 14:00 Integration of Survival Analysis and Workflow Assistant on a Hybrid Interactive Machine Learning Tool for Whole Slide Image Analysis Adding survival prediction and a chat assistant to an AI tool that helps doctors spot tumor regions on scanned tissue slides.
La Jolla Institute for Immunology La Jolla, CA
	Talk Tue Apr 13 17:20 The Immune Epitope and Cancer Epitopes Databases as Tools to Support Development and Testing of Biologics mAbs
Massachusetts General Hospital Boston, MA
	Talk Tue Apr 13 11:40 From start-up to scale: cGMP considerations and lessons from a cell therapy hub Manufacturing
Mayo Clinic Rochester, MN
	Talk Tue Apr 13 11:00 AI and Machine Learning in design, conduct and analysis of Immunotherapy and Antibody Research AI & Data
MIT Cambridge, MA
	Talk Tue Apr 13 11:00 Stable cell culture solutions: managing pH and temperature in bioreactors Bioprocessing
Northeastern University Boston, MA
	Talk Tue Apr 13 17:20 Hybrid modality engineering Protein Engineering
San Diego State University San Diego, CA
	Talk Tue Apr 13 13:05 Clinical Trials: title to be announced
Stanford University Stanford, CA
	Talk Tue Apr 13 11:00 Directed Evolution For Engineering Novel Proteins Protein Engineering
Stony Brook Medicine Stony Brook, NY
stonybrookmedicine.edu Academic Academic medical center of Stony Brook University on Long Island, including Stony Brook University Hospital.	Talk Wed Apr 14 13:20 Pathomics tools to Map and Quantify TILs in Cancer for Precision Oncology AI & Data